查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301134

伽玛刀市场规模、份额和趋势分析报告：按适应症、按地区、细分市场趋势，2023-2030 年

Gamma Knife Market Size, Share & Trends Analysis Report By Indication (Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10个工作天内

价格

伽玛刀市场增长和趋势

根据 Grand View Research, Inc 的最新报告，到 2030 年，全球伽马刀市场预计将达到 6.264 亿美元。

预计 2023 年至 2030 年復合年增长率为 5.0%。 癌症、脑肿瘤和其他神经系统疾病患病率的上升、手术中心越来越多地采用这些仪器、对微创手术 (MIS) 的日益青睐以及仪器技术的进步正在推动市场。这是推动市场发展的几个因素之一。预计

伽玛刀疗法用于治疗各种脑部和神经系统疾病，例如脑肿瘤、脑转移、癫痫和动静脉畸形。 由于具有安全性、微观精度、术后并发症少、切口少等多种优点，手术中心的需求正在不断增加。

技术进步提高了手术的准确性。 例如，Leksell 伽玛刀型号 U、B、C/4C 和 Perfexion 升级为 Icon，提高了手术的微观精度，并鼓励手术中心采用该设备。 根据 Elekta AB 发布的一份报告，每年约有 70,000 名患者接受伽玛刀手术。 由于目标疾病患病率不断上升以及对 MIS 的偏好不断增加，预计这一数字在预测期内还会增加。

此外，与开放手术相比，对 MIS 的需求不断增长也是推动这种治疗方法越来越多采用的主要因素之一。 伽玛刀治疗比开放手术创伤更小，恢復也更快。 减少住院时间可确保经济可行性并降低医疗费用。 更少的切口和更少的术后并发症是推动微创手术需求的主要因素。

伽玛刀市场报告亮点

  • 到 2022 年，恶性肿瘤将成为最大的适应症，功能障碍细分市场将在预测期内增长最快
  • 由于癌症患病率上升、医疗基础设施发展以及新兴经济体经济快速发展，亚太地区将在 2022 年占据最大收入份额
  • 伽玛刀是该公司的专利产品，因此该市场上只有 Elekta AB 运营。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 产品
    • 针长
    • 治疗
    • 区域范围
    • 估计/预测时间表
  • 调查方法
  • 信息获取
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场形成和验证
  • 型号详细信息
    • 产品流分析（模型 1）
    • 批量价格分析（模型 2）
  • 辅助信息列表
  • 主要信息列表
  • 目的

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 衝突快照

第 3 章伽玛刀市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 采用和增长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 伽玛刀市场分析工具
    • 行业分析-波特分析
    • PESTEL 分析
    • 主要交易和战略联盟分析
    • 市场进入策略

第四章伽马刀市场：估算和趋势分析

  • 2022 年和 2030 年适应症市场份额
  • 细分仪表板
  • 按适应症划分的全球伽玛刀市场展望
  • 2018-2030 年以下市场规模、预测和趋势分析
    • 恶性肿瘤
    • 良性肿瘤
    • 血管疾病
    • 功能障碍
    • 眼科

第五章伽马刀市场：区域估算和趋势分析

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2022 年区域市场份额和主要参与者
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2018-2030年市场应用、预测及趋势分析
  • 北美
    • 2018-2030 年市场预估和预测（收入）
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳大利亚
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 6 章竞争格局

  • 主要市场进入者的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商情况
    • 主要经销商和渠道合作伙伴名单
    • 主要客户
    • 2022 年主要参与者的市场份额分析
    • Elekta AB
    • Huiheng Medical, Inc.
    • MASEP Medical Science Technology Development（Shenzhen）Co., Ltd.
    • Akesis Inc.
Product Code: GVR-1-68038-581-6

Gamma Knife Market Growth & Trends

The global gamma knife market size is expected to reach USD 626.4 million by 2030, according to a new report by Grand View Research, Inc. It is expected to grow at a CAGR of 5.0% from 2023 to 2030. The increasing prevalence of cancer, brain tumors, and other neurological diseases, rising adoption of these instruments in surgery centers, growing preference for Minimally Invasive Surgeries (MIS), and technological advancements in the device are among few factors expected to drive the market.

Gamma knife therapy is used for the treatment of various brain and neurological disorders such as brain tumors, brain metastases, epilepsy, and arteriovenous malformations. Demand for these instruments in surgery centers is growing due to their various advantages such as safety, micro-precision, lack of postsurgical complications, and lack of incisions.

Technological advancements have improved precision in surgery. For instance, the up-gradation of Leksell Gamma Knife models U, B, C/4C, and Perfexion to Icon provided micro-precision in surgery and boosted the adoption of this device in surgery centers. According to reports published by Elekta AB, approximately 70,000 patients undergo gamma knife surgery each year. This number is expected to increase over the forecast period owing to the rising prevalence of target diseases and increasing preference for MIS.

In addition, the growing demand for MIS over open surgeries is one of the key factors responsible for increasing the adoption of this therapy. Gamma knife treatment procedure results in fewer traumas and faster recovery as compared to open surgeries. It helps reduce hospital stays, thus ensuring economic viability and reduction in medical expenses. Lack of incisions and post-surgical complications are key factors responsible for boosting the demand for minimally invasive surgeries.

Gamma Knife Market Report Highlights

  • Malignant tumors emerged as the largest indication segment in 2022. The functional disorders segment is anticipated to witness the fastest growth over the forecast period
  • The Asia Pacific held the largest revenue share in 2022 owing to the rising incidence of cancer, developments in healthcare infrastructure, and rapid economic development across major emerging economies
  • Elekta AB is the only player operating in this market since Gamma Knife is a patent-protected trademark product of the company

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Needle Length
    • 1.1.3. Therapy
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Snapshot

Chapter 3. Gamma knife Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Gamma knife Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis
    • 3.4.4. Market Entry Strategies

Chapter 4. Gamma Knife Market: Indication Estimates & Trend Analysis

  • 4.1. Indication Market Share, 2022 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Gamma Knife Market by Indication Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Malignant Tumors
      • 4.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Benign Tumors
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Vascular Disorders
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4. Functional Disorders
      • 4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.5. Ocular
      • 4.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Gamma Knife Market: Regional Estimates & Trend Analysis

  • 5.1. Regional market share analysis, 2022 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Regional Market Share and Leading Players, 2022
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa
  • 5.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
  • 5.6. North America
    • 5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. U.S.
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 5.6.3. Canada
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 5.7. Europe
    • 5.7.1. UK
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Competitive Scenario
      • 5.7.1.3. Regulatory framework
      • 5.7.1.4. Reimbursement scenario
      • 5.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 5.7.2. Germany
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory framework
      • 5.7.2.4. Reimbursement scenario
      • 5.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 5.7.3. France
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory framework
      • 5.7.3.4. Reimbursement scenario
      • 5.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 5.7.4. Italy
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory framework
      • 5.7.4.4. Reimbursement scenario
      • 5.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 5.7.5. Spain
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory framework
      • 5.7.5.4. Reimbursement scenario
      • 5.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 5.7.6. Denmark
      • 5.7.6.1. Key country dynamics
      • 5.7.6.2. Competitive Scenario
      • 5.7.6.3. Regulatory framework
      • 5.7.6.4. Reimbursement scenario
      • 5.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 5.7.7. Sweden
      • 5.7.7.1. Key country dynamics
      • 5.7.7.2. Competitive Scenario
      • 5.7.7.3. Regulatory framework
      • 5.7.7.4. Reimbursement scenario
      • 5.7.7.5. Market estimates and forecasts, 2018 - 2030
    • 5.7.8. Norway
      • 5.7.8.1. Key country dynamics
      • 5.7.8.2. Competitive Scenario
      • 5.7.8.3. Regulatory framework
      • 5.7.8.4. Reimbursement scenario
      • 5.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 5.8. Asia Pacific
    • 5.8.1. Japan
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Competitive Scenario
      • 5.8.1.3. Regulatory framework
      • 5.8.1.4. Reimbursement scenario
      • 5.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 5.8.2. India
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Competitive Scenario
      • 5.8.2.3. Regulatory framework
      • 5.8.2.4. Reimbursement scenario
      • 5.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 5.8.3. China
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Competitive Scenario
      • 5.8.3.3. Regulatory framework
      • 5.8.3.4. Reimbursement scenario
      • 5.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 5.8.4. South Korea
      • 5.8.4.1. Key country dynamics
      • 5.8.4.2. Competitive Scenario
      • 5.8.4.3. Regulatory framework
      • 5.8.4.4. Reimbursement scenario
      • 5.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 5.8.5. Australia
      • 5.8.5.1. Key country dynamics
      • 5.8.5.2. Competitive Scenario
      • 5.8.5.3. Regulatory framework
      • 5.8.5.4. Reimbursement scenario
      • 5.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 5.8.6. Thailand
      • 5.8.6.1. Key country dynamics
      • 5.8.6.2. Competitive Scenario
      • 5.8.6.3. Regulatory framework
      • 5.8.6.4. Reimbursement scenario
      • 5.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 5.9. Latin America
    • 5.9.1. Brazil
      • 5.9.1.1. Key country dynamics
      • 5.9.1.2. Competitive Scenario
      • 5.9.1.3. Regulatory framework
      • 5.9.1.4. Reimbursement scenario
      • 5.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 5.9.2. Mexico
      • 5.9.2.1. Key country dynamics
      • 5.9.2.2. Competitive Scenario
      • 5.9.2.3. Regulatory framework
      • 5.9.2.4. Reimbursement scenario
      • 5.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 5.9.3. Argentina
      • 5.9.3.1. Key country dynamics
      • 5.9.3.2. Competitive Scenario
      • 5.9.3.3. Regulatory framework
      • 5.9.3.4. Reimbursement scenario
      • 5.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 5.10. MEA
    • 5.10.1. South Africa
      • 5.10.1.1. Key country dynamics
      • 5.10.1.2. Competitive Scenario
      • 5.10.1.3. Regulatory framework
      • 5.10.1.4. Reimbursement scenario
      • 5.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 5.10.2. Saudi Arabia
      • 5.10.2.1. Key country dynamics
      • 5.10.2.2. Competitive Scenario
      • 5.10.2.3. Regulatory framework
      • 5.10.2.4. Reimbursement scenario
      • 5.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 5.10.3. UAE
      • 5.10.3.1. Key country dynamics
      • 5.10.3.2. Competitive Scenario
      • 5.10.3.3. Regulatory framework
      • 5.10.3.4. Reimbursement scenario
      • 5.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 5.10.4. Kuwait
      • 5.10.4.1. Key country dynamics
      • 5.10.4.2. Competitive Scenario
      • 5.10.4.3. Regulatory framework
      • 5.10.4.4. Reimbursement scenario
      • 5.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2022
    • 6.3.4. Elekta AB
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Huiheng Medical, Inc.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Akesis Inc.
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 4 U.S. Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Canada Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 6 Europe Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 7 Europe Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 8 U.K. Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 9 Germany Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 10 France Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 11 Italy Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 12 Spain Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 13 Denmark Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 14 Sweden Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Norway Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Japan Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 19 China Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 20 India Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 21 Australia Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 22 Thailand Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 23 South Korea Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 24 Latin America Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 25 Latin America Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 26 Brazil Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 27 Mexico Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 28 Argentina Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 31 South Africa Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 33 UAE Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Kuwait Gamma Knife market, by indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Gamma Knife market: market outlook
  • Fig. 14 Gamma Knife market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Gamma Knife market driver impact
  • Fig. 18 Gamma Knife market restraint impact
  • Fig. 19 Gamma Knife market strategic initiatives analysis
  • Fig. 20 Gamma Knife market: Indication movement analysis
  • Fig. 21 Gamma Knife market: Indication outlook and key takeaways
  • Fig. 22 Malignant tumors market estimates and forecast, 2018 - 2030
  • Fig. 23 Benign tumors market estimates and forecast, 2018 - 2030
  • Fig. 24 Vascular disorders market estimates and forecast, 2018 - 2030
  • Fig. 25 Functional disorders therapy market estimates and forecast, 2018 - 2030
  • Fig. 26 Ocular market estimates and forecast, 2018 - 2030
  • Fig. 27 Global Gamma Knife market: Regional movement analysis
  • Fig. 28 Global Gamma Knife market: Regional outlook and key takeaways
  • Fig. 29 Global market shares and leading players
  • Fig. 30 North America market share and leading players
  • Fig. 31 Europe market share and leading players
  • Fig. 32 Asia Pacific market share and leading players
  • Fig. 33 Latin America market share and leading players
  • Fig. 34 Middle East & Africa market share and leading players
  • Fig. 35 North America: SWOT
  • Fig. 36 Europe SWOT
  • Fig. 37 Asia Pacific SWOT
  • Fig. 38 Latin America SWOT
  • Fig. 39 MEA SWOT
  • Fig. 40 North America, by country
  • Fig. 41 North America
  • Fig. 42 North America market estimates and forecast, 2018 - 2030
  • Fig. 43 U.S.
  • Fig. 44 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 45 Canada
  • Fig. 46 Canada market estimates and forecast, 2018 - 2030
  • Fig. 47 Europe
  • Fig. 48 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 49 U.K.
  • Fig. 50 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 51 Germany
  • Fig. 52 Germany market estimates and forecast, 2018 - 2030
  • Fig. 53 France
  • Fig. 54 France market estimates and forecast, 2018 - 2030
  • Fig. 55 Italy
  • Fig. 56 Italy market estimates and forecast, 2018 - 2030
  • Fig. 57 Spain
  • Fig. 58 Spain market estimates and forecast, 2018 - 2030
  • Fig. 59 Denmark
  • Fig. 60 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 61 Sweden
  • Fig. 62 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 63 Norway
  • Fig. 64 Norway market estimates and forecast, 2018 - 2030
  • Fig. 65 Asia Pacific
  • Fig. 66 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 67 Japan
  • Fig. 68 Japan market estimates and forecast, 2018 - 2030
  • Fig. 69 China
  • Fig. 70 China market estimates and forecast, 2018 - 2030
  • Fig. 71 India
  • Fig. 72 India market estimates and forecast, 2018 - 2030
  • Fig. 73 Australia
  • Fig. 74 Australia market estimates and forecast, 2018 - 2030
  • Fig. 75 Thailand
  • Fig. 76 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 77 South Korea
  • Fig. 78 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 79 Latin America
  • Fig. 80 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 81 Brazil
  • Fig. 82 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 83 Mexico
  • Fig. 84 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 85 Argentina
  • Fig. 86 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 87 Middle East and Africa
  • Fig. 88 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 89 Saudi Arabia
  • Fig. 90 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 91 South Africa
  • Fig. 92 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 93 UAE
  • Fig. 94 UAE market estimates and forecast, 2018 - 2030
  • Fig. 95 Kuwait
  • Fig. 96 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 97 Participant categorization - Gamma Knife market
  • Fig. 98 Market share of key market players - Gamma Knife market